
MRF Meets with FDA on State of Melanoma Drug Devel...
The Melanoma Research Foundation (MRF) met on November 15, 2010 with high-level officials at the Food and Drug Administration (FDA), including Dr. Richard Pazdur, the Direc...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
The Melanoma Research Foundation (MRF) met on November 15, 2010 with high-level officials at the Food and Drug Administration (FDA), including Dr. Richard Pazdur, the Direc...
The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab. ...
[jwplayer |config=mrfplayer | file=https://melaresearcstg.wpengine.com/sites/default/files/upload/VTS_01_1.flv | image=https://melaresearcstg.wpengine.com/sites/default/fil...
MRF will be hosting a Capitol Hill briefing to discuss the current controversies around indoor tanning and skin cancer with Representatives Carolyn B. Maloney (D-NY), Charl...
The National Council on Skin Cancer Prevention (NCSCP) asks patients to submit comments in advance of a FDA hearing to review current classification or regulatory controls ...
Oct 30, 2025 ET